SN
Sanofi
SNY · NASDAQ
$39.92 -1.84% (-$0.75)
1M -9.76%
Market Cap 86.8B €
P/E Ratio 21.93x
Div. Yield 5.95%
ROE 5.52%
Bulios Fair Price
$56.91
42.6% upside
Current Price
$39.92
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SNY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
7/9Valuation
85 /100
Cheap P/E 21.93x
EV/EBITDA 8.38x
P/S 1.77x
Growth
38 /100
Stable EPS growth 0.21%
Rev. growth 4.82%
FCF growth 6.81%
Profitability
80 /100
Strong Gross margin 73.02%
Net margin 8.09%
Op. margin 14.80%
Quality
28 /100
Poor ROIC 5.33%
ROE 5.52%
ROA 3.07%
Debt
82 /100
Low Debt/Equity 0.34x
Current ratio 0.99x
Int. coverage 15.04x
Stability
67 /100
Stable Beta 0.30x
Rev. volatility 1.98%
EPS volatility 39.36%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SNY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Belén Garijo López
Employees
76,493
Headquarters
Paris
Upcoming events
30 OCT
Earnings
Upcoming earnings report